Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$143.93 - $207.3 $204,380 - $294,366
-1,420 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$96.1 - $151.18 $136,462 - $214,675
1,420 New
1,420 $207,000
Q1 2019

May 15, 2019

SELL
$77.0 - $99.34 $186,340 - $240,402
-2,420 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$83.85 - $110.34 $107,411 - $141,345
-1,281 Reduced 34.61%
2,420 $208,000
Q3 2018

Nov 14, 2018

BUY
$97.14 - $113.31 $67,900 - $79,203
699 Added 23.28%
3,701 $419,000
Q2 2018

Aug 14, 2018

SELL
$74.5 - $108.91 $877,461 - $1.28 Million
-11,778 Reduced 79.69%
3,002 $312,000
Q1 2018

May 15, 2018

BUY
$58.36 - $83.18 $10,913 - $15,554
187 Added 1.28%
14,780 $1.17 Million
Q4 2017

Feb 14, 2018

SELL
$77.49 - $98.41 $484,002 - $614,668
-6,246 Reduced 29.97%
14,593 $1.17 Million
Q3 2017

Nov 14, 2017

BUY
$84.87 - $109.54 $1.77 Million - $2.28 Million
20,839
20,839 $1.84 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.